Skip to main content
Equibles

WELLS FARGO & COMPANY/MN

Position in RNAC — Cartesian Therapeutics, Inc.

CIK 72971 SAN FRANCISCO, CA
Back to RNAC Full portfolio

Position in RNAC

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$131,749
+$107,273 QoQ
Shares Held
12,644
+217.7% QoQ
Ownership
0.042%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#51
of 95 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RNAC Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,575,562,942 across 417 Biotechnology names. RNAC ranks #277 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 749,528 $372,313,040
2 HALO
Halozyme Therapeutics, Inc.
 1,390,428 $108,828,797
3 ALNY
Alnylam Pharmaceuticals, Inc.
 310,047 $93,333,446
4 REGN
Regeneron Pharmaceuticals, Inc.
 140,802 $87,795,677
5 EXEL
Exelixis, Inc.
 717,840 $39,057,673
6 RVMD
Revolution Medicines, Inc.
 178,780 $33,481,916
7 ARGX
Argenx SE
 34,453 $31,964,458
8 INCY
Incyte Corp
 255,064 $28,914,053

All Filings in RNAC

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $131,749 12,644
2026-03-31 $24,476 3,980
2025-12-31 $84,803 11,762
2025-09-30 $80,574 7,884
2025-06-30 $60,604 5,833
2025-03-31 $65,305 4,955
2024-12-31 $86,809 4,847
2024-09-30 $36,736 2,279
2024-06-30 $63,932 2,367
2024-03-31 $26,168 40,260
2023-12-31 $24,247 35,192
2023-09-30 $29,468 27,801
2023-06-30 $51,417 45,909
2023-03-31 $1,902 1,369
2022-12-31 $883 782
2022-09-30 $1,248 761
2022-06-30 $1,117 853
2022-03-31 $113,021 91,887
2021-12-31 $381,126 116,910
2021-09-30 $581,608 139,810
2021-06-30 $229,175 54,827
2021-03-31 $104,173 23,022
2020-12-31 $350,188 115,574
2020-09-30 $394,779 159,186
2020-06-30 $357,395 125,844
2020-03-31 $457 190